Kumiko Yoshimatsu

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki, Daichi Yamasoba, Izumi Kimura et al. · Nature · 2022 · 749 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +9

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Akatsuki Saito, Takashi Irie, Rigel Suzuki et al. · Nature · 2021 · 681 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B.

Murray J. Towle, Kathleen A. Salvato, John Budrow et al. · PubMed · 2001 · 491 citations

Medicine, Medicinal Chemistry, Oncology +15

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Daichi Yamasoba, Izumi Kimura, Hesham Nasser et al. · Cell · 2022 · 348 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

Tomokazu Tamura, Jumpei Ito, Keiya Uriu et al. · Nature Communications · 2023 · 347 citations · Full text

Life Sciences, Genetics, Infectious Diseases +12